Women still being left out of medical research: report

March 3, 2014 by Mary Brophy Marcus, Healthday Reporter
Women still being left out of medical research: report
Despite 1993 law mandating inclusion in government-funded trials, experts say there's a long way to go.

(HealthDay)—Two decades after the passage of a landmark law mandating that women be represented in government-funded medical research, a new report reveals that the world of science is still ignoring women's unique health issues far more than it should.

"The science that informs medicine routinely fails to consider the impact of sex and gender, and this occurs at some of the earliest stages of research—from animal to human studies," said report author Dr. Paula Johnson. The new findings are scheduled for release Monday at a national summit on 's health issues in Boston.

While women are now more routinely included in and an entire field of women's health has emerged beyond reproductive health, "there are still enormous gaps in the scientific process as it relates to women," said Johnson, who is executive director of The Connors Center for Women's Health at Brigham and Women's Hospital in Boston.

The latest statistics are indeed grim:

  • Less than one-third of cardiovascular clinical trial participants are women, and only one-third of trials that include women report sex-specific outcomes. Yet, cardiovascular disease is the number one cause of death among U.S. women.
  • Less than 45 percent of animal studies on anxiety and depression use female animals, although depression is a leading cause of disease among women worldwide.
  • Lung cancer researchers often fail to include an analysis of data by sex or gender-specific factors, despite the fact that lung cancer behaves differently in nonsmoking women than in nonsmoking men. This disease kills more women each year than breast, ovarian and uterine cancers combined.
  • A woman's overall lifetime risk of developing Alzheimer's disease is almost twice that of a man, and it has been thought that this is simply because women live longer. However, hormones may play a role.

One expert explained the importance of including women in medical research.

"Unless you study the populations that you're treating, you really don't know how that population is going to respond," said Dr. Lynn Gordon, associate dean of diversity affairs, at the David Geffen School of Medicine at the University of California, Los Angeles.

However, Gordon said, a lot of researchers don't want to do studies on women of childbearing age due to their monthly hormonal fluctuations, for example.

"When you're doing animal studies, you want to make things as standardized as possible," she explained. "If you add in gender, how do you standardize, especially considering the hormone issues," but that doesn't excuse the disparity, Gordon noted.

Gordon said pregnancy and safety to unborn children are concerns, too. "Again, I'm not excusing it or saying it's an appropriate reason, but it is a concern investigators have," she pointed out.

Gordon added that more studies on the natural history of diseases in women could be conducted, too, because they only require following women, not exposing anyone to experimental therapy.

Johnson said there may be a need for more rigorous enforcement of the law. "The law's scope may be too limited to address all the dynamics of the problem," she said.

She called on political, scientific and business leaders to push efforts to apply sex differences to research.

"We really have to raise awareness," Johnson said. "There's an overall lack of awareness among our population."

The report also recommends more transparency in research on drugs and medical devices, and suggests that clinical trials should carry a disclaimer if a study has not included enough female participants. Johnson said another goal is to adopt clinical care practices that use a gender-based lens in health care and .

Women need to drive the conversation, said Dr. Eve Higginbotham, vice dean for diversity and inclusion at the Perelman School of Medicine at the University of Pennsylvania, in Philadelphia.

"We still have a lot of bias embedded in academic medicine, and certainly it comes down to the people actually doing the studies," said Higginbotham. "Women are still struggling to get to the highest levels of . In many cases, women are not the primary drivers in many of these studies."

Higginbotham noted that the highest levels of academia in medical schools are still slim on women—women only represent 5 percent of medical professors in the United States.

"Change takes time, and it's going to take a number of factors to drive that," Higginbotham said. "Having the summit is a good first step in at least acknowledging the lack of progress that has been made and making people more aware."

Explore further: Ovary removal might raise odds for bone loss, heart disease

More information: Here is more information on the women's health summit.

Related Stories

Ovary removal might raise odds for bone loss, heart disease

February 14, 2014
(HealthDay)—Older women who had their ovaries removed before menopause are at increased risk for bone loss and cardiovascular disease, according to a new study.

Nepal gender bias sparks health crisis in young women: Amnesty

February 20, 2014
Hundreds of thousands of young women living in impoverished areas of rural Nepal have developed a debilitating uterus condition which usually only occurs after the menopause, Amnesty International said Thursday.

Hispanic women are less aware of weight and heart disease risk

January 2, 2014
Minority women tend to be less aware of the increased risk of cardiovascular disease (CVD) they face by being overweight or obese. The results of a study that compared Hispanic and non-Hispanic white women based on their ...

What is the safest way to stop postmenopausal hormone therapy?

February 11, 2014
When the time comes for postmenopausal women to discontinue hormone therapy (HT), little is known about the best way to do so with minimal symptoms. A new study that explores optimal approaches to manage symptoms such as ...

Hormone therapy linked to better survival after lung cancer diagnosis in women

February 26, 2014
Survival among people with lung cancer has been better for women than men, and the findings of a recent study indicate that female hormones may be a factor in this difference. The combination of estrogen plus progesterone ...

Younger Hispanic women face higher risk of death from heart attack

November 19, 2013
Younger Hispanic women face a higher risk of death in hospitals after a heart attack, are more likely to suffer from co-existing conditions such as diabetes, and are less likely to undergo percutaneous coronary interventions ...

Recommended for you

Forces from fluid in the developing lung play an essential role in organ development

January 23, 2018
It is a marvel of nature: during gestation, multiple tissue types cooperate in building the elegantly functional structures of organs, from the brain's folds to the heart's multiple chambers. A recent study by Princeton researchers ...

Anemia discovery offers new targets to treat fatigue in millions

January 22, 2018
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells. The finding sheds light on iron-restricted ...

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.